Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosus
- Resource Type
- Article
- Source
- In
Biomaterials June 2022 285 - Subject
- Language
- ISSN
- 0142-9612